Okyo Pharma Limited ADR (OKYO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2022 | 03-2022 | 03-2021 | |
| Cash Flows From Operating Activities | |||
| Net Income | -5,365 | -6,218 | -3,379 |
| Depreciation Amortization | 2 | 2 | 2 |
| Other Working Capital | 1,154 | -1,024 | 1,045 |
| Other Operating Activity | 789 | 1,772 | 733 |
| Operating Cash Flow | $-3,420 | $-5,468 | $-1,600 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -3 | -2 | -7 |
| Net Acquisitions | N/A | 0 | -11 |
| Investing Cash Flow | $-3 | $-2 | $-18 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 1,748 | 2,153 | 7,827 |
| Financing Cash Flow | $1,748 | $2,153 | $7,827 |
| Exchange Rate Effect | N/A | -872 | 445 |
| Beginning Cash Position | 2,421 | 6,889 | 235 |
| End Cash Position | 746 | 2,701 | 6,889 |
| Net Cash Flow | $-1,675 | $-4,189 | $6,654 |
| Free Cash Flow | |||
| Operating Cash Flow | -3,420 | -5,468 | -1,600 |
| Free Cash Flow | -3,420 | -5,468 | -1,600 |